WST — WEST PHARMACEUTICAL SERVICES INC
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 105770 ·
Last close
$370.44
Market Cap
$26.07B
52W High
$385.75
52W Low
$223.52
ADV30
547,493
Next earnings
2026-10-22
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 872,300,000 | 329,200,000 | 191,900,000 | 154,000,000 | 4,076,400,000 | 435,800,000 | 1,086,200,000 |
| Mar 2026 | 844,900,000 | 296,400,000 | 181,100,000 | 138,800,000 | 4,109,800,000 | 521,400,000 | 1,119,400,000 |
| Dec 2025 | 805,000,000 | 303,900,000 | 175,100,000 | 132,100,000 | 4,270,000,000 | 791,300,000 | 1,094,000,000 |
| Sep 2025 | 804,600,000 | 294,300,000 | 174,500,000 | 140,000,000 | 4,105,800,000 | 628,500,000 | 1,054,300,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$662,200,000
Investing CF
$-225,300,000
Financing CF
$-496,700,000
CapEx
$-225,300,000
Dividends Paid
$-62,400,000
Buybacks
$-457,100,000
EPS Diluted TTM
$7.81
As of
2026-07-26
Balance + Analyst (yfinance extras)
Retained Earnings
$4,624,100,000
Inventory
$447,400,000
Receivables
$712,000,000
ST Investments
—
EBIT TTM
$698,100,000
Pretax Income TTM
$693,600,000
Interest Exp TTM
$4,500,000
Analysts
15
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,326,799,872
EBITDA
$912,200,000
Free Cash Flow
$277,937,504
Enterprise Value
$24,246,900,736
Total Cash
$435,800,000
Total Debt
$316,500,000
Shares Out
70,375,762
Trailing EPS
$7.82
Book Value
$42.47
ROE
19.1%
ROA
11.4%
Div Yield
0.25%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,074,100,000 | 636,100,000 | 493,700,000 | 4,270,000,000 | 1,094,000,000 | 3,176,000,000 | 754,800,000 |
| Dec 2024 | 2,893,200,000 | 590,900,000 | 492,700,000 | 3,643,400,000 | 961,100,000 | 2,682,300,000 | 653,400,000 |
| Dec 2023 | 2,949,800,000 | 707,400,000 | 593,400,000 | 3,829,500,000 | 948,500,000 | 2,881,000,000 | 776,500,000 |
| Dec 2022 | 2,886,900,000 | 760,800,000 | 585,900,000 | 3,616,800,000 | 931,900,000 | 2,684,900,000 | 724,000,000 |
TTM Snapshot
Revenues TTM
$2,879,200,000
NetIncome TTM
$507,700,000
OpCashFlow TTM
$0
Assets (Latest)
$4,270,000,000
Forward EPS
$9.98
Max Pain — expiry 2026-12-18
max pain strike: $280.00 · spot: $369.70 · call oi: 859 · put oi: 684
Expected Move to 2026-12-18:
±$43.04
(11.64%) —
implied range
$326.66 –
$412.74
· ATM straddle on $370.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RYLPF | KONINKLIJKE PHILIPS NV | $24.48B | $25.05 | — |
| PHG | KONINKLIJKE PHILIPS NV | $24.40B | $24.96 | — |
| FSNUY | Fresenius SE & Co. KGaA | $29.92B | $13.28 | — |
| GEHC | GE HealthCare Technologies Inc. | $30.10B | $66.63 | — |
| MDLN | Medline Inc. | $30.44B | $34.70 | — |
News headlines (Yahoo Finance, 1h cache)
West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says
2026-09-22 15:07 · Yahoo
Layoffs, Cyber Disruptions, Annex 1 Upgrades Might Change The Case For Investing In West (WST)
2026-09-20 19:10 · Yahoo
What Is Drawing Attention To West Pharmaceutical Services (WST)?
2026-09-20 14:07 · Yahoo
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
2026-09-18 13:21 · Yahoo
Is West Pharmaceutical Services Stock Outperforming the Nasdaq?
2026-09-16 11:50 · Yahoo
Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup
2026-09-25 14:53 · Yahoo
Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now
2026-09-24 15:46 · Yahoo
Veeva Unveils Falcon Router to Streamline Biopharma Case Routing
2026-09-23 17:02 · Yahoo
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
2026-09-22 17:28 · Yahoo
1 S&P 500 Stock with Exciting Potential and 2 We Ignore
2026-09-22 08:37 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.